3D Systems Shows Signs of Recovery with Mixed Performance Across Segments
On August 3, 2026, 3D Systems (NYSE:DDD) reported second-quarter results that showed signs of improvement in its Healthcare segment while the Industrial division continued to struggle. Total revenue remained flat at $94.6 million for Q2, but excluding divested software units from 2025, sales grew by 1.4%. The company's Healthcare Solutions business saw a 6.8% increase in revenue driven primarily by strong growth in Med Tech and Dental segments. The Industrial segment reported declining revenues due to the exit of a non-core product line and softer hardware services demand. Despite this, Aerospace & Defense and Data Center Infrastructure within that division grew sharply. Adjusted EBITDA improved significantly year-over-year but still showed losses for Q2 2026. CEO Jeffrey Graves highlighted new products gaining traction as additive manufacturing emerges from a multi-year downturn. The company raised $53.2 million through the issuance of shares, increasing its cash reserves to $129.0 million. However, gross margin declined due to lower-margin hardware sales and pricing pressure. Institutional interest in 3D Systems increased with more hedge funds holding positions, while short interest remained high at nearly a quarter of the float.
Tickers: $DDD
Topics: 3D Printing EBITDA Improvement Healthcare Solutions Industrial Growth